Cerulean Pharma (CERU) Set to Open up 100% Following News of Strategic Collaboration with Novartis

October 19, 2016 8:24 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Cerulean Pharma (NASDAQ: CERU) was set to open higher by 100% following news that it entered a strategic collaboration with Novartis.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Momentum Movers, Trader Talk

Add Your Comment